NORD Corporate Council
The NORD Corporate Council is composed of a select group of leading companies committed to helping people with rare diseases. Members include pharmaceutical, biotechnology and medical device companies that are marketing or developing therapeutic or diagnostic products, as well as companies that are engaged in other aspects of health care for the rare disease/orphan product community such as specialty pharmacies and distributors, consulting firms, integrated health care systems, and contract research organizations.
Corporate Council members have the opportunity to utilize NORD's knowledge of orphan product research and development, rare diseases patients, and on-going legislative and policy issues related to the rare disease community. View the full list of membership benefits.
NORD sponsors two annual meetings and on-going teleconferences. The major area of focus are policy and regulation, patient access and reimbursement, and research and intelligence. View the meeting schedule.
All companies who join the Council must adhere to the Council Code of Conduct.